It frames this as necessary because GLP-1 therapy reduces meal size and slows gastric emptying, which can lower overall micronutrient intake before any supplement is added
GLP-1 receptor agonists include semaglutide, liraglutide, dulaglutide, and tirzepatide, used for type 2 diabetes and weight management
This dual-receptor targeting creates synergistic effects that: Optimize Glucose Processing : Tirzepatide was more effective than selective GLP-1 agonists in increasing insulin secretion and sensitivity, improving meal tolerance, and suppressing glucagon secretion Enhance Cellular Metabolism : The medication improves how your body processes sugar at the cellular level, promoting better energy utilization Reduce Inflammation : Tirzepatide has shown anti-inflammatory effects, which are important in reducing chronic, low-grade inflammationa key driver of aging Support Cardiovascular Health : Tirzepatide may help reduce the risk of cardiovascular events by improving cholesterol levels, lowering blood pressure, and promoting weight loss The Microdosing Advantage: Precision Medicine at Its Best Our program utilizes a sophisticated microdosing approach that advocates say reduces costs and side effects while maintaining weight loss, then can help with weight maintenance
Eur J Nutr (2020) 59(7):333940
Pontiroli, A
Summary Oral GLP-1 drops can be a useful, needle-free alternative for many people when prescribed and monitored by a licensed provider
